Recent studies revealed that methylated ZNF582 in the promoter was an essential epigenetic mechanism for cancer silence [26], and it has been demonstrated that hypermethylation occurred in EC tissues [20,27]; however, the study of methylated ZNF582 in EC plasma has not been reported. The gene discussed is ZNF582; the disease is cancer.